197 related articles for article (PubMed ID: 11713602)
1. Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver.
Platzer P; Thalhammer T; Reznicek G; Hamilton G; Zhang R; Jäger W
Int J Oncol; 2001 Dec; 19(6):1287-93. PubMed ID: 11713602
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of camptothecin, a potent topoisomerase I inhibitor, in the isolated perfused rat liver.
Platzer P; Thalhammer T; Hamilton G; Ulsperger E; Rosenberg E; Wissiack R; Jäger W
Cancer Chemother Pharmacol; 2000; 45(1):50-4. PubMed ID: 10647501
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of topotecan in the isolated perfused rat liver: identification of three novel metabolites.
Platzer P; Schaden S; Thalhammer T; Hamilton G; Rosenberg B; Silgoner I; Jäger W
Anticancer Res; 1998; 18(4A):2695-700. PubMed ID: 9703931
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of UCN-01 in isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
Hagenauer B; Maier-Salamon A; Thalhammer T; Zöllner P; Senderowicz A; Jäger W
Oncol Rep; 2004 May; 11(5):1069-75. PubMed ID: 15069549
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver.
Jäger W; Zembsch B; Wolschann P; Pittenauer E; Senderowicz AM; Sausville EA; Sedlacek HH; Graf J; Thalhammer T
Life Sci; 1998; 62(20):1861-73. PubMed ID: 9600328
[TBL] [Abstract][Full Text] [Related]
6. Loperamide inhibits the biliary excretion of irinotecan (CPT-11) in the rat isolated perfused liver.
Tobin PJ; Hong Y; Seale JP; Rivory LP; McLachlan AJ
J Pharm Pharmacol; 2005 Jan; 57(1):39-45. PubMed ID: 15638991
[TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I.
Zhang R; Li Y; Cai Q; Liu T; Sun H; Chambless B
Cancer Chemother Pharmacol; 1998; 41(4):257-67. PubMed ID: 9488594
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
[TBL] [Abstract][Full Text] [Related]
9. Identification of the metabolites of irinotecan, a new derivative of camptothecin, in rat bile and its biliary excretion.
Atsumi R; Suzuki W; Hakusui H
Xenobiotica; 1991 Sep; 21(9):1159-69. PubMed ID: 1788984
[TBL] [Abstract][Full Text] [Related]
10. Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2).
Jäger W; Gehring E; Hagenauer B; Aust S; Senderowicz A; Thalhammer T
Life Sci; 2003 Oct; 73(22):2841-54. PubMed ID: 14511769
[TBL] [Abstract][Full Text] [Related]
11. Hepatic metabolism and biliary excretion of valerenic acid in isolated perfused rat livers: role of Mrp2 (Abcc2).
Maier-Salamon A; Trauner G; Hiltscher R; Reznicek G; Kopp B; Thalhammer T; Jäger W
J Pharm Sci; 2009 Oct; 98(10):3839-49. PubMed ID: 19156843
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of the new ribonucleotide reductase inhibitor amidox in the isolated perfused rat liver.
Salamon A; Vielnascher E; Hagenauer B; Szekeres T; Szekeres-Fritzer M; Thalhammer T; Jäger W
Anticancer Res; 2000; 20(5B):3521-6. PubMed ID: 11131656
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
Maier-Salamon A; Hagenauer B; Reznicek G; Szekeres T; Thalhammer T; Jäger W
J Pharm Sci; 2008 Apr; 97(4):1615-28. PubMed ID: 17724663
[TBL] [Abstract][Full Text] [Related]
14. Irinotecan (CPT-11) metabolites in human bile and urine.
Lokiec F; du Sorbier BM; Sanderink GJ
Clin Cancer Res; 1996 Dec; 2(12):1943-9. PubMed ID: 9816153
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and biliary excretion of trimetrexate by the isolated perfused rat liver.
Webster LK; Tong WP; McCormack JJ
Cancer Lett; 1985 Oct; 29(1):65-71. PubMed ID: 2933139
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and elimination of 5,6-dimethylxanthenone-4-acetic acid in the isolated perfused rat liver.
Webster LK; Ellis AG; Kestell P; Rewcastle GW
Drug Metab Dispos; 1995 Mar; 23(3):363-8. PubMed ID: 7628302
[TBL] [Abstract][Full Text] [Related]
17. Disposition of isosteviol in the rat isolated perfused liver.
Jin H; Wang J; Gerber JP; Davey AK
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):593-7. PubMed ID: 20082626
[TBL] [Abstract][Full Text] [Related]
18. Identification of the metabolites of 9-nitro-20(S)-camptothecin in rats.
Li K; Chen X; Zhong D; Li Y
Drug Metab Dispos; 2003 Jun; 31(6):792-7. PubMed ID: 12756214
[TBL] [Abstract][Full Text] [Related]
19. Biliary excretion mechanism of CPT-11 and its metabolites in humans: involvement of primary active transporters.
Chu XY; Kato Y; Ueda K; Suzuki H; Niinuma K; Tyson CA; Weizer V; Dabbs JE; Froehlich R; Green CE; Sugiyama Y
Cancer Res; 1998 Nov; 58(22):5137-43. PubMed ID: 9823324
[TBL] [Abstract][Full Text] [Related]
20. The metabolism of oestrone and some other steroids in isolated perfused rat and guinea pig livers.
Roy AB; Curtis CG; Powell GM
Xenobiotica; 1987 Nov; 17(11):1299-313. PubMed ID: 2963441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
